Showing results (381-390 of 579) with videos related to

Sort By:
Pageof 58
British Journal of Haematology|August 18, 2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main cloneHongying You, Weiqin Yao, Lingzhi Yan, et al.
HLA|June 18, 2024
HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCTShuang Liu, Tengteng Zhang, Xiaojin Wu, et al.
BMC Infectious Diseases|May 30, 2019
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 dataJie Jin, Depei Wu, Yang Liu, et al.
BMC Cancer|January 30, 2016
Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access ProgramXin Du, Jie Jin, Zhen Cai, et al.
The International Journal of Biochemistry & Cell Biology|December 3, 2014
Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residuesGuodong Chen, Xin Xu, Jiefei Tong, et al.
Journal of Clinical Apheresis|September 14, 2022
The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet countsPamela Lopert, Sohair Abdelrahman, Christopher A Graybill, et al.
American Journal of Cancer Research|July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
British Journal of Haematology|November 12, 2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapyLinghao Li, Zihao Wang, Chongsheng Qian, et al.
American Journal of Hematology|September 30, 2017
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remissionNorbert-Claude Gorin, Myriam Labopin, Thomas Pabst, et al.
American Journal of Cancer Research|October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Pageof 58